Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2024-03-18 00:00:00 ET · period of report 2024-03-14 · accession 0001628280-24-011685 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-18 | 2024-03-15 | MYGN | Haas Kevin Richard | CTO | F - Tax | $21.16 | -3,306 | 136.7K | -2% | -$70.0K | |
| 2024-03-18 | 2024-03-14 | MYGN | Haas Kevin Richard | CTO | A - Grant | $0.00 | +35.2K | 140.0K | +34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-15 | F | D | 3,306 | $21.16 | 136,672 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-14 | A | A | 35,178 | $0.00 | 139,978 | D | — | — |